CAS: 52727-57-8; Methyl 2-Amino-5-Bromobenzoate

该化合物是一种属于苯甲酸酯类别的有机化合物,其特点是附于苯并酸衍生物的甲基酯功能组,该物质组还被氨基酸组和溴原子进一步取代,该化合物一般是晶状固体,其特点是有机溶剂中具有中等溶解性,但由于其缺水芳香结构,在水中溶解性较低.氨基氨基生物组的存在具有基本特性,允许其参与各种化学反应,例如核循环替代物.溴原子是进一步发挥功能的有用处理器,成为有机合成中有价值的中间体.甲基2-氨基-5-溴苯并可用于开发药品,农用化学品和其他精密化学品,因为其具有再活性和进一步衍生的潜力.应当参考安全数据,以便处理和储存,如所有化学物质一样,用于处理和储存.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号67-56-1 甲醇 | CAS号5794-88-7 2-氨基-5-溴苯甲酸 | CAS号77-78-1 硫酸二甲酯 | CAS号544-92-3 氰化亚铜 | CAS号134-20-3 邻氨基苯甲酸甲酯 | CAS号87-48-9 5-溴靛红 | CAS号75-87-6 三氯乙醛 | CAS号363185-87-9 4-氨基-3-甲氧羰基苯硼酸频哪醇酯 | CAS号606-00-8 2-氨基3,5-二溴苯甲酸甲酯 | CAS号39263-32-6 2-氨基-5-溴代苯甲腈 | CAS号20364-59-4 6-溴-4-羟基-2-苯基喹啉 | CAS号289039-83-4 2-氨基-5-溴-3-碘苯甲酸甲酯 | CAS号304853-89-2 2-(2-AMINO-5-BR... | CAS号29632-82-4 5-溴-苯并[d]异噻唑-3(... | CAS号243989-52-8 methyl 2-amino-... | CAS号20712-12-3 2-氨基-5-溴苯甲醇 | CAS号5344-90-1 2-氨基苯甲醇

合成工艺路线路线简述

    氰化亚铜 以 N-甲基吡咯烷酮 作为反应溶剂,化学反应 4.0H,反应生成 5-溴氨基苯甲酸甲酯
    参考文献: Antibacterial Agents[fr] Agents Antibacteriens
    标题: Antibacterial Agents[fr] Agents Antibacteriens

    海关参考信息

    专利信息


    专利号:US-6225329-B1
    优先权日:1998-03-12
    标 题 :Modulators of protein tyrosine phosphatases (PTPases)
    发明人:RICHTER LUTZ STEFAN; ANDERSEN HENRIK SUNE; VAGNER JOSEF; JEPPESEN CLAUS BEKKER; MOELLER NIELS PETER HUNDAHL; BRANNER SVEN; SU JING; BAKIR FARID; JUDGE LUKE MILBURN
    权利人:NOVO NORDISK AS
    摘要:The present invention provides novel compounds of Formula 1, compositions containing these compounds, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like, n wherein A, R 1 , R 2 , R 3 , R 4 , R 16 and R 17 are as defined in the specification. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

    专利号:WO-9946236-A1
    优先权日:1998-03-12
    标题 :Modulators of protein tyrosine phosphatases (ptpases)
    发明人:RICHTER LUTZ STEFAN; ANDERSEN HENRIK SUNE; VAGNER JOSEF; JEPPESEN CLAUS BEKKER; MOELLER NIELS PETER HUNDAHL; BRANNER SVEN; SU JING; BAKIR FARID; JUDGE LUKE MILBURN
    权利人:NOVO NORDISK AS; ONTOGEN CORP
    摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPases) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

    专利号:EP-1062199-A1
    优先权日:1998-03-12
    标题 :Modulators of protein tyrosine phosphatases (ptpases)
    发明人:RICHTER LUTZ STEFAN; ANDERSEN HENRIK SUNE; VAGNER JOSEF; JEPPESEN CLAUS BEKKER; MOLLER NIELS PETER HUNDAHL; BRANNER SVEN; SU JING; BAKIR FARID; JUDGE LUKE MILBURN
    权利人:NOVO NORDISK AS; ONTOGEN CORP
    摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPases) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

    专利号:WO-2025023769-A1
    优先权日:2023-07-25
    标 题:Novel synthesis method of 18f-rucaparib
    发明人:CHEON CHEOL-HONG; PARK JINJAE; SEO JUAN
    权利人:UNIV KOREA RES & BUS FOUND
    摘要:The present invention relates to a method for efficiently preparing rucaparib for a PET image. More specifically, the present invention relates to an improved preparation method for synthesizing [18F]-rucaparib in excellent yield by means of a pathway for synthesizing a pinacol boronate derivative, which is a key intermediate, by using, as a starting material, a 2-iodoaniline derivative prepared by a novel synthesis method.

    专利号:US-11702394-B2
    优先权日:2018-02-23
    标 题 :Inhibitors of phospholipid synthesis and methods of use
    发明人:GOUW ARVIN; FELSHER DEAN W; JIN FENG; ZARE RICHARD N; MARGULIS KATHERINE; SCHOW STEVEN R; GREENHOUSE ROBERT J; LOUGHHEAD DAVID; RICHARDS STEVEN
    权利人:UNIV LELAND STANFORD JUNIOR
    摘要:Inhibitors of Glycerol 3-Phosphate Acyltransferase (GPAT) are provided; and methods of use in the treatment of cancer; and treatment of conditions relating to metabolic syndrome and hyperlipidemia.

    专利号:US-9096624-B2
    优先权日:2009-06-01
    标 题:Amino pyrimidine anticancer compounds
    发明人:CREW ANDREW P; SHERMAN DAN; APPARI RAMA DEVI; CHEN XIN; CHILUKURI RAMESH; DONG HANQING; FERRARO CATERINA; FOREMAN KENNETH; GUPTA RAMESH C; LI AN-HU; STOLZ KATHRYN M; VOLK BRIAN; ZAHLER ROBERT
    权利人:OSI PHARMACEUTICALS LLC
    摘要:Compounds of Formula 1, as shown below and defined herein: n n n n n n n n n n n n and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by FAK.
    天津安浩生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ahpharmatech.com
    企业联系电话:022-84840027👤
    📞天津安浩生物科技有限公司 ⚠️参考联系方式
    联系人:马经理
    电话:022-84840027

    传真:022-84840027
    邮箱:sales@ahpharmatech.com
    通信地址: 天津市东丽区四纬路10号2-201
    邮编: 300300
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:天津市东丽区四纬路10号2-201
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海泰矶林实业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.tajilin.com
    企业联系电话:021-50630626,18964684208👤
    📞上海泰矶林实业有限公司 ⚠️参考联系方式
    联系人:销售部
    电话:021-50630626,18964684208
    手机:18964684208
    传真:021-50563898
    邮箱:sales001@tajilin.com
    通信地址: 上海市松江区沈砖公路5808号14幢5层536B室
    邮编: 201619
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市松江区沈砖公路5808号14幢5层536B室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    烟台知数医药化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.zhishumedicine.com
    企业联系电话:0535-5482128👤
    📞烟台知数医药化工有限公司 ⚠️参考联系方式
    联系人:郝志风
    电话:0535-5482128
    手机:18660030801
    传真:0535-5989245;5482130
    邮箱:sales@widepharmtech.com
    通信地址: 烟台市桃村镇海口路103号
    邮编: 264000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:烟台市桃村镇海口路103号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Weidel E, Et Al. Structure Optimization Of 2-Benzamidobenzoic Acids As Pqsd Inhibitors For Pseudomonas Aeruginosa Infections And Elucidation Of Binding Mode By Spr, Std Nmr, And Molecular Docking. J Med Chem. 2013 Aug 8;56(15):6146-55.
    [参考文献]: Nagahisa Yamaoka, Et Al. Structure-Activity Relationships Of New N-Acylanthranilic Acid Derivatives As Plasminogen Activator Inhibitor-1 Inhibitors. Chem Pharm Bull (Tokyo). 2011;59(2):215-24.

    合成参考文献


    摘要:Silva, V. L. M.; Pinto, D. C. G. A.; Santos, C. M. M.; Rocha, D. H. A., Science of Synthesis Knowledge Updates, (2022) 3, 296.
    摘要:Gosmini, C.; Corpet, M., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 1, 631.
    摘要:Cruz, F. A.; Dong, V. M., Science of Synthesis, (2019) , 125.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知